Federal health regulators say they’ll update the hemp industry on their CBD review by late summer or fall.
Dr. Amy Abernethy, who leads the U.S. Food and Drug Administration’s work group on cannabinoids such as CBD, said Friday the agency is “enthusiastic about research into the therapeutic benefits of CBD products but also need to balance safety.”
She added the public has until Tuesday to weigh in on how CBD should be allowed in foods and dietary supplements.
“We plan to report on our progress around end of summer/early fall,” she wrote on Twitter.
The FDA has made no promises about expanding CBD access. But the agency has said it is open to changes and started its review May 31.
Subscribe to our Newsletter